Harsha Sen, M.D.

Dr. Harsha Sen joined Eye Center South in 2017 as a successful retinal surgeon and published researcher. He has dedicated himself to the care of his patients, striving for the best possible medical and surgical outcomes while incorporating the latest innovations and surgical techniques.

Dr. Sen received his undergraduate and medical degrees from the University of North Carolina at Chapel Hill and went on to complete his Internship in Internal Medicine at his alma mater. He served his Residency in Ophthalmology at the University of Virginia and his Fellowship in Vitreoretinal Surgery at Duke University.

Dr. Sen has been published in numerous medical journals, collaborated in the development of the first intraocular sustained-release drug implant, and continues to be active in the clinical research of new medications to treat diabetic retinal disease. In 2020, as part of an international research trial, he performed the first-ever intravitreal injection of a drug with the potential to treat diabetic macular ischemia, a currently untreatable cause of permanent visual impairment in patients with diabetes. Throughout his career, he has been listed in Best Doctors in America, and is currently a Castle Connolly Top Doctor. He is a member of the medical honor society Alpha Omega Alpha, a Fellow of the American Academy of Ophthalmology and a member of the American Society of Retina Specialists.

In March of 2022, Dr. Sen recently contributed a chapter in the highly regarded textbook “The Duke Manual of Vitreoretinal Surgery” produced for Duke University Eye Center in North Carolina as part of its internationally renowned ophthalmology training programs.

Dr. Sen resides in Dothan, Alabama.